Global Vaccine Adjuvants Market to Reach USD 2,851.7 Million by 2033, Propelled by the Rising Incidences of Infectious Diseases and Allergies

December 27, 2024 | Healthcare

The latest report by IMARC, titled “Vaccine Adjuvants Market Report by Product Type (Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, and Others), Route of Administration (Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal, and Others), Diseases (Cancer, Infectious Diseases, and Others), Application (Research, Commercial), and Region 2025-2033”, finds that the global vaccine adjuvants market size reached USD 1,107.0 Million in 2024. Vaccine adjuvants are compounds that improve the body’s immunogenic response against antigens. They increase the ability of the vaccines to induce long-term protection against infections. Presently, aluminum salts and MF59 are the only adjuvants found fit for human use. In recent years, the demand for vaccine adjuvants has escalated as they increase antibody titers, reduce required antigen doses, induce a rapid immune response and long-lasting memory, and enhance the immune response in the elderly and young children.

Global Vaccine Adjuvants Market Trends:

One of the primary factors driving the market is the rising incidences of infectious diseases and allergies, such as human immunodeficiency virus (HIV/AIDS), cancer, human papillomavirus (HPV), and tuberculosis. Additionally, the need for advanced treatment options for prevailing and emerging fatal diseases has increased the need to develop vaccines possessing long-lasting effects on immunization. Other than this, governments of numerous nations are taking initiatives for immunization and improvements in adjuvants for human consumption. They are also focusing on enhancing the healthcare infrastructure and increasing investments in research and development (R&D) of new therapeutics, which is creating a positive market outlook. Furthermore, with the sudden coronavirus (COVID-19) outburst, the demand for effective and safe vaccine adjuvants is constantly increasing. On account of these factors, IMARC Group expects the market value to reach USD 2,851.7 Million by 2033, expanding at a CAGR of 10.53% during the forecast period (2025-2033).

Market Summary:

  • Based on the product type, the market has been divided into adjuvant emulsions, pathogen components, particulate adjuvants, combination adjuvants, and others.
  • On the basis of the route of administration, the market has been segmented into oral, intramuscular, intranasal, subcutaneous, intradermal, and others.
  • Based on the diseases, the market has been categorized into cancer, infectious diseases, and others.
  • On the basis of the application, the market has been bifurcated into research and commercial.
  • Region-wise, the market has been classified into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the market has also been analyzed, with some of the key players being Adjuvatis, Agenus Inc., Croda International Plc, CSL Limited, Dynavax Technologies, InvivoGen, Novavax Inc., OZ Biosciences, Phibro Animal Health Corporation, SEPPIC, SPI Pharma, etc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Million USD
Segment Coverage Product Type, Route of Administration, Diseases, Application, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Adjuvatis, Agenus Inc., Croda International Plc, CSL Limited, Dynavax Technologies, InvivoGen, Novavax Inc., OZ Biosciences, Phibro Animal Health Corporation, SEPPIC, SPI Pharma, etc.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Vaccine Adjuvants Market to Reach USD 2,851.7 Million by 2033, Propelled by the Rising Incidences of Infectious Diseases and Allergies
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials